Why are we doing this study?
Gestational Diabetes Mellitus (GDM) is a type of diabetes that affects some people during pregnancy and is sometimes referred to as ‘pregnancy induced diabetes’. The body’s need for insulin (a hormone that helps sugar get into the cells) increases during pregnancy, and GDM can occur when the body cannot make enough insulin. Having GDM during pregnancy can increase the risk of other pregnancy complications, such as having a larger sized baby, pre-eclampsia (a condition that causes high blood pressure) and having a Caesarean section birth. Current data on the best timing for induction of labour for patients with GDM is inconclusive. International guidelines differ in timing of induction of labour, varying from 37-weeks to 39-weeks of pregnancy. A randomized control trial would allow us to assess the outcomes associated with the induction of labour at 38-weeks’ gestation compared to current expectant management.
To help inform and develop the design of a future clinical trial, our research team would like to gain insight from patients and health care providers to assess their opinions in participating or supporting a clinical trial to evaluate induction of labour at 38-weeks’ gestation compared to current expectant management in those pregnancies with GDM.
Who can participate?
We are inviting patients and health care providers to complete a 5-minute survey to obtain their perspectives on participating in a clinical trial.
Patients are eligible to complete this survey if they:
• are at least 16 years old, AND
• able to comprehend and communicate in English or French, AND
• are currently pregnant or up to 12-months postpartum, AND
• have been diagnosed with diabetes in their current or most recent pregnancy, AND
• are currently residing in Canada.
Health care providers are eligible to complete this survey if:
• they are currently providing care to the pregnant population, AND
• their professional status allows them to counsel pregnant people on pregnancy, including delivery recommendations, AND
• able to comprehend and communicate in English, AND
• are currently residing in Canada
How can you participate?
If you are interested in participating, please click on the link on the image below based on your population to be directed to the survey.
As a token of our appreciation, you will be invited to provide your email address to receive a $5.00 gift card to a local coffee shop upon completion of the survey. Please note there is a limit of one gift card per participant.
Questions:
If you have any questions about this study, please contact the research team.
By phone at 613-737-8899 ext. 73840 or email at omniresearch@toh.ca.
Note: Email is considered a non-secure form of communication as it may be accessed by unauthorized third parties.
Le diabète sucré gestationnel (DSG), parfois appelé «diabète induit par grossesse», est un type de diabète qui touche certaines personnes pendant la grossesse. Les besoins de l’organisme en insuline (une hormone qui permet au sucre d’entrer dans les cellules) augmentent pendant la grossesse, et le DSG peut survenir lorsque l’organisme produit une quantité insuffisante d’insuline. Le fait de souffrir du DSG pendant la grossesse peut augmenter le risque d’autres complications liées à la grossesse, telles que la naissance d’un bébé de plus grande taille, la prééclampsie (une maladie qui entraîne une hausse de la tension artérielle) et un accouchement par césarienne.
Les données actuelles quant au meilleur moment pour déclencher le travail chez les patientes atteintes d’un DSG demeurent non concluantes. Les directives internationales diffèrent quant au moment du déclenchement artificiel du travail, variant de 37 à 39 semaines de grossesse. Un essai contrôlé à affectation aléatoire nous permettrait d’évaluer les résultats associés au déclenchement du travail à la 38e semaine de gestation en comparaison avec la prise en charge non interventionniste actuelle.
Afin de contribuer à l’élaboration d’un essai clinique ultérieur, notre équipe de recherche souhaite connaître l’opinion des patientes et des prestataires de soins de santé quant à leur participation ou leur soutien à un essai clinique visant à évaluer le déclenchement artificiel du travail à 38 semaines de gestation en comparaison avec la prise en charge non interventionniste actuelle des femmes enceintes aux prises avec le DSG. Diabetes Mellitus (GDM) is a type of diabetes that affects some people during pregnancy and is sometimes referred to as ‘pregnancy induced diabetes’. The body’s need for insulin (a hormone that helps sugar get into the cells) increases during pregnancy, and GDM can occur when the body cannot make enough insulin. Having GDM during pregnancy can increase the risk of other pregnancy complications, such as having a larger sized baby, pre-eclampsia (a condition that causes high blood pressure) and having a Caesarean section birth. Current data on the best timing for induction of labour for patients with GDM is inconclusive. International guidelines differ in timing of induction of labour, varying from 37-weeks to 39-weeks of pregnancy. A randomized control trial would allow us to assess the outcomes associated with the induction of labour at 38-weeks’ gestation compared to current expectant management.
Qui peut participer?
Nous invitons les patientes et les prestataires de soins de santé à répondre à un questionnaire de cinq (5) minutes afin de connaître leur point de vue concernant la participation à un essai clinique.
Les patientes seront admissibles à répondre à ce questionnaire si :
Les prestataires de soins de santé seront admissibles à répondre à ce questionnaire si :
Comment procéder si vous souhaitez participer?
Si vous souhaitez participer, veuillez cliquer sur le lien de l’image ci-dessous qui correspond à votre situation, et vous serez dirigé vers le questionnaire.
Questions:
Pour toute question au sujet de cette étude, veuillez communiquer avec l’équipe de recherche, soit par téléphone, au 613-737-8899, poste 73840, ou par courriel à omniresearch@toh.ca.
Remarque : Le courrier électronique est considéré comme une forme de communication non sécurisée, car des tiers non autorisés pourraient y avoir accès.
